Global Transdermal Drug Patches Supply, Demand and Key Producers, 2026-2032
Description
The global Transdermal Drug Patches market size is expected to reach $ 8243 million by 2032, rising at a market growth of 1.8% CAGR during the forecast period (2026-2032).
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
This report studies the global Transdermal Drug Patches production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transdermal Drug Patches and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Drug Patches that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transdermal Drug Patches total production and demand, 2021-2032, (M Pieces)
Global Transdermal Drug Patches total production value, 2021-2032, (USD Million)
Global Transdermal Drug Patches production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Pieces), (based on production site)
Global Transdermal Drug Patches consumption by region & country, CAGR, 2021-2032 & (M Pieces)
U.S. VS China: Transdermal Drug Patches domestic production, consumption, key domestic manufacturers and share
Global Transdermal Drug Patches production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Pieces)
This report profiles key players in the global Transdermal Drug Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem, Nitto Denko, Grünenthal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Drug Patches market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Pieces) and average price (USD/Piece) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transdermal Drug Patches Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Transdermal Drug Patches Market, Segmentation by Type:
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Global Transdermal Drug Patches Market, Segmentation by Application:
Rx Channel
OTC Channel
Companies Profiled:
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Key Questions Answered:
1. How big is the global Transdermal Drug Patches market?
2. What is the demand of the global Transdermal Drug Patches market?
3. What is the year over year growth of the global Transdermal Drug Patches market?
4. What is the production and production value of the global Transdermal Drug Patches market?
5. Who are the key producers in the global Transdermal Drug Patches market?
6. What are the growth factors driving the market demand?
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
This report studies the global Transdermal Drug Patches production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transdermal Drug Patches and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Drug Patches that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transdermal Drug Patches total production and demand, 2021-2032, (M Pieces)
Global Transdermal Drug Patches total production value, 2021-2032, (USD Million)
Global Transdermal Drug Patches production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Pieces), (based on production site)
Global Transdermal Drug Patches consumption by region & country, CAGR, 2021-2032 & (M Pieces)
U.S. VS China: Transdermal Drug Patches domestic production, consumption, key domestic manufacturers and share
Global Transdermal Drug Patches production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Pieces)
Global Transdermal Drug Patches production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Pieces)
This report profiles key players in the global Transdermal Drug Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem, Nitto Denko, Grünenthal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Drug Patches market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Pieces) and average price (USD/Piece) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transdermal Drug Patches Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Transdermal Drug Patches Market, Segmentation by Type:
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Global Transdermal Drug Patches Market, Segmentation by Application:
Rx Channel
OTC Channel
Companies Profiled:
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Key Questions Answered:
1. How big is the global Transdermal Drug Patches market?
2. What is the demand of the global Transdermal Drug Patches market?
3. What is the year over year growth of the global Transdermal Drug Patches market?
4. What is the production and production value of the global Transdermal Drug Patches market?
5. Who are the key producers in the global Transdermal Drug Patches market?
6. What are the growth factors driving the market demand?
Table of Contents
149 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

